JPWO2021032836A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021032836A5
JPWO2021032836A5 JP2022510804A JP2022510804A JPWO2021032836A5 JP WO2021032836 A5 JPWO2021032836 A5 JP WO2021032836A5 JP 2022510804 A JP2022510804 A JP 2022510804A JP 2022510804 A JP2022510804 A JP 2022510804A JP WO2021032836 A5 JPWO2021032836 A5 JP WO2021032836A5
Authority
JP
Japan
Prior art keywords
cells
tcrαβ
population
progenitor
hpcs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022510804A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545416A (ja
JP2022545416A5 (https=
Publication date
Priority claimed from GBGB1911958.5A external-priority patent/GB201911958D0/en
Application filed filed Critical
Publication of JP2022545416A publication Critical patent/JP2022545416A/ja
Publication of JP2022545416A5 publication Critical patent/JP2022545416A5/ja
Publication of JPWO2021032836A5 publication Critical patent/JPWO2021032836A5/ja
Pending legal-status Critical Current

Links

JP2022510804A 2019-08-20 2020-08-20 Ｔ細胞の生産方法 Pending JP2022545416A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1911958.5A GB201911958D0 (en) 2019-08-20 2019-08-20 Methods of t cell production
GB1911958.5 2019-08-20
PCT/EP2020/073332 WO2021032836A1 (en) 2019-08-20 2020-08-20 Methods of t cell production

Publications (3)

Publication Number Publication Date
JP2022545416A JP2022545416A (ja) 2022-10-27
JP2022545416A5 JP2022545416A5 (https=) 2023-08-18
JPWO2021032836A5 true JPWO2021032836A5 (https=) 2023-08-18

Family

ID=68099410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022510804A Pending JP2022545416A (ja) 2019-08-20 2020-08-20 Ｔ細胞の生産方法

Country Status (9)

Country Link
US (1) US20220267729A1 (https=)
EP (1) EP4017966A1 (https=)
JP (1) JP2022545416A (https=)
KR (1) KR20220047376A (https=)
CN (1) CN114364790A (https=)
AU (1) AU2020332059A1 (https=)
CA (1) CA3150425A1 (https=)
GB (1) GB201911958D0 (https=)
WO (1) WO2021032836A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022241558A1 (en) * 2021-05-18 2022-11-24 The University Of British Columbia A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof
GB202205572D0 (en) 2022-04-14 2022-06-01 Adaptimmune Ltd Engineered T cells
GB202208545D0 (en) 2022-06-10 2022-07-27 Adaptimmune Ltd Production of immune cells
IL320084A (en) * 2022-10-05 2025-06-01 Garuda Therapeutics Inc Pluripotent T cell populations derived from stem cells and their progenitors
GB202318950D0 (en) 2023-12-12 2024-01-24 Adaptimmune Ltd Production of immune cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7575925B2 (en) * 2002-12-10 2009-08-18 Sunnybrook Health Sciences Centre Cell preparations comprising cells of the T cell lineage and methods of making and using them
ES2724451T3 (es) * 2010-02-04 2019-09-11 Univ Pennsylvania ICOS regula fundamentalmente la expansión y la función de linfocitos Th17 humanos inflamatorios
MX2018005274A (es) * 2015-10-30 2019-09-19 The Regents Of The Universtiy Of California Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
GB201616238D0 (en) * 2016-09-23 2016-11-09 Adaptimmune Ltd Modified T cells
EP3572502B1 (en) * 2017-01-20 2023-01-11 Kyoto University Method for producing cd8alpha +beta + cytotoxic t cells
CA3056542A1 (en) * 2017-03-15 2018-09-20 Oxford Biomedica (Uk) Limited Method
CA3056942A1 (en) * 2017-03-29 2018-10-04 Sunnybrook Research Institute Engineered t-cell modulating molecules and methods of using same
EP3654986A2 (en) * 2017-07-19 2020-05-27 Fate Therapeutics, Inc. Compositions and methods for immune cell modulation in adoptive immunotherapies
GB202102297D0 (en) * 2021-02-18 2021-04-07 Adaptimmune Ltd Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells

Similar Documents

Publication Publication Date Title
JP7560502B2 (ja) 多能性幹細胞からｈｌａホモ接合免疫細胞への指向分化方法
Sonoda Human CD34-negative hematopoietic stem cells: The current understanding of their biological nature
Sakabe et al. Human cord blood-derived primitive progenitors are enriched in CD34+ c-kit− cells: correlation between long-term culture-initiating cells and telomerase expression
CN102329769A (zh) 一种获得造血干细胞的方法
de Haar et al. Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation
CN110997904B (zh) 改进造血移植物的方法
EP3170895A1 (en) Production method for pluripotent stem cells having antigen-specific t cell receptor gene
US20150087065A1 (en) Method for generation of conditionally immortalized hematopoietic progenitor cell lines with multiple lineage potential
CN112574952A (zh) 一种工程化人体免疫细胞、其制备方法及应用
JP2023164892A (ja) 造血前駆細胞マーカー
US20190085291A1 (en) Selection of human hematopoetic stem cells using epcr
JPWO2021032836A5 (https=)
CN115698270A (zh) 一种通过iPS细胞生产再生T细胞的方法
Ferreira et al. Reprogramming cancer cells to antigen-presenting cells
JPWO2021032855A5 (https=)
CN113980143A (zh) 靶向cd276的嵌合抗原受体、嵌合抗原受体t细胞及制备方法和制药应用
CN109371005B (zh) 一种hla-0201限制性padi4表位多肽及其应用
WO2002103033A1 (fr) Procede pour detecter et isoler des cellules hepatiques indifferenciees au moyen de dlk
JPWO2021032852A5 (https=)
JP5757942B2 (ja) 表現型の可塑性を示す細胞を生成する方法
AU2019376495B2 (en) Method for producing erythroid cells
CN117480249A (zh) 包含未重排的t细胞受体(tcr)基因座的干细胞及其使用方法
CN107541484A (zh) 二倍体红鲫尾鳍细胞系2nFC及其构建方法和应用
Crawford The T-antigens of Simian virus 40 and polyoma virus: their role in transformation
WO2026011501A1 (zh) 一种靶向cd19的car-nk细胞及其制备方法和应用